Blue Earth Diagnostics, Inc.- Medical Affairs
Blue Earth Diagnostics, a Bracco company, is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management for cancer patients. Its first product, Axumin® (fluciclovine F 18), was approved by the FDA in 2016. For more information, please visit www.axumin.com.